Viewing Study NCT04350957


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2025-12-28 @ 8:39 PM
Study NCT ID: NCT04350957
Status: WITHDRAWN
Last Update Posted: 2023-04-26
First Post: 2020-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose Imaging Technique (LITE)
Sponsor: University of Chicago
Organization:

Study Overview

Official Title: Low-dose Imaging Technique (LITE) MRI Gadavist® (Gadobutrol)
Status: WITHDRAWN
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: PI left institution due to family emergency prior to IRB approval.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to compare the diagnostic accuracy of a breast MRI when using a smaller dose of contrast compared to a full dose of contrast.

Each patient will be injected with a low-dose and standard dose of Gadavist® acquired on two separate days. Both low-dose and standard-dose images for each patient will allow matched comparison for comprehensive quantitative evaluation. To evaluate these diagnostic methods we need volunteers who are willing to allow us to take a number of different MRI pictures of their breasts. The scans we are asking you to volunteer for now is for research purposes only and will have no effect on the medical care you receive from your doctors.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: